CADL vs CLX · $592.0M cap vs P/E 15, rev $7.10B
Candel Therapeutics Inc (CADL) versus The Clorox Company (CLX) — a side-by-side from cached financials, not a winner call.
Candel Therapeutics Inc (CADL) is a biotechnology company listed on NASDAQ.
The Clorox Company (CLX) is a household & personal products company listed on US.
CADL does not have a complete income-statement cache yet.
Latest reported CLX revenue for 2025-06-30 was $7.10B. Net income was $824.0M. CLX currently screens at market cap $10.89B and trailing P/E 14.6.
CADL currently screens at market cap $592.0M. CLX currently screens at market cap $10.89B and trailing P/E 14.6.
Not investment advice. Open the CADL and CLX stock pages for the full models.
Not investment advice.